Works matching IS 03407004 AND DT 2013 AND VI 62 AND IP 5
Results: 15
Circulating tumor cells as therapy-related biomarkers in cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 5, p. 931, doi. 10.1007/s00262-012-1387-1
- By:
- Publication type:
- Article
FcγRΙΙB controls the potency of agonistic anti-TNFR mAbs.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 5, p. 941, doi. 10.1007/s00262-013-1398-6
- By:
- Publication type:
- Article
CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 5, p. 851, doi. 10.1007/s00262-013-1392-z
- By:
- Publication type:
- Article
A novel melittin-MhIL-2 fusion protein inhibits the growth of human ovarian cancer SKOV cells in vitro and in vivo tumor growth.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 5, p. 889, doi. 10.1007/s00262-013-1401-2
- By:
- Publication type:
- Article
Modulation of p38 MAPK signaling enhances dendritic cell activation of human CD4 Th17 responses to ovarian tumor antigen.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 5, p. 839, doi. 10.1007/s00262-013-1391-0
- By:
- Publication type:
- Article
An introduction to mass cytometry: fundamentals and applications.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 5, p. 955, doi. 10.1007/s00262-013-1416-8
- By:
- Publication type:
- Article
Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 5, p. 967, doi. 10.1007/s00262-013-1422-x
- By:
- Publication type:
- Article
CD40 immunotherapy for pancreatic cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 5, p. 949, doi. 10.1007/s00262-013-1427-5
- By:
- Publication type:
- Article
Toward next-generation cancer immunotherapy: 10th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23-25, 2012.
- Published in:
- 2013
- By:
- Publication type:
- Report
Effects of cyclophosphamide and IL-2 on regulatory CD4 T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 5, p. 897, doi. 10.1007/s00262-013-1397-7
- By:
- Publication type:
- Article
Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 5, p. 863, doi. 10.1007/s00262-013-1395-9
- By:
- Publication type:
- Article
Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 5, p. 829, doi. 10.1007/s00262-013-1393-y
- By:
- Publication type:
- Article
Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 5, p. 909, doi. 10.1007/s00262-013-1396-8
- By:
- Publication type:
- Article
Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 5, p. 875, doi. 10.1007/s00262-013-1394-x
- By:
- Publication type:
- Article
Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 5, p. 919, doi. 10.1007/s00262-012-1379-1
- By:
- Publication type:
- Article